Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

Medical - Diagnostics & Research

Healthcare
$1.59 +2.44%

+$0.13 today

Market cap
$52.08M
Beta
1.79
P/E (TTM)
-3.9
EPS (TTM)
-$1.39
52W Low $2.33High $8.51

Volume 0.64M

Average 0.38M

Balance Sheet

Inspect the capital base behind the business.

Assets

$25.76M

FY 2025 · Annual

-26.6% YoY

Liabilities

$57.22M

FY 2025 · Annual

+20.8% YoY

Equity

-$31.46M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents32.95M19.99M9.43M8.64M11.58M
Short-term Investments904K433K000
Net Receivables1.44M2.01M484K1.61M1.13M
Inventory304K00410K446K
Other Current Assets2.94M2.12M782K1.1M2.15M
Total Current Assets39.14M25.54M10.7M11.76M15.31M
Property, Plant & Equipment (Net)8.37M10.85M5.44M2.76M2.82M
Goodwill18.68M0000
Intangible Assets61.72M61.63M56.6M14.61M0
Long-term Investments0001.7M607K
Tax Assets00000
Other Non-current Assets31.65M2.07M2.16M4.26M7.03M
Total Non-current Assets120.42M74.56M64.19M23.32M10.45M
Total Assets159.56M100.09M74.89M35.08M25.76M
Account Payables1.81M1.25M953K2.28M2.54M
Short-term Debt1.31M0000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.71M4.43M4.01M2.17M2.89M
Total Current Liabilities14.12M12.11M7.19M7.28M12.08M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities76.68M45.66M45.03M37.71M43.46M
Total Non-current Liabilities80.23M48.39M47.23M40.08M45.15M
Total Liabilities94.35M60.5M54.42M47.36M57.22M
Common Stock252.95M294.93M310.3M338.24M369.21M
Retained Earnings(187.77M)(260.68M)(289.88M)(350.54M)(400.76M)
Accumulated OCI37K39K49K21K86K
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity65.22M39.59M20.47M(12.27M)(31.46M)
Total Debt5.68M3.54M2.87M3.66M3.5M
Net Debt(27.27M)(16.45M)(6.56M)(4.97M)(8.09M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$28.2M
Receivables$157.0K
Inventory$382.0K
Other Current$1.8M
Total Current Assets$30.5M
PP&E (Net)$8.9M
Long-term Investments$425.0K
Other Non-current$574.0K
Total Non-current Assets$9.9M
Total Assets$40.4M

Analysis

Selected assets total $40.4M for Latest. The largest visible component is Cash & Equivalents at $28.2M, about 69.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 21, 2026
10-QQuarterly reportAug 10, 2026
8-KCurrent reportAug 10, 2026
S-8S-8 filingJul 24, 2026
4Statement of changes in beneficial ownershipJul 6, 2026

How much cash does IMDX have?

Insight Molecular Diagnostics Inc. (IMDX) reported $11.58M in cash and equivalents in fiscal 2025.

How much debt does IMDX carry?

Insight Molecular Diagnostics Inc. (IMDX) reported $3.50M of total debt, with net debt of -$8.09M.